 | • レポートコード：GIR-23F3779 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Communicable Diseases Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の伝染病治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 伝染病治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・HIV、インフルエンザ、結核、マラリア、肝炎、HPV アプリケーション別セグメントは次のように区分されます。 ・病院、診療所、その他 世界の伝染病治療薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・Novartis、Gilead、GSK、Janssen Pharmaceutical、Roche、BioCryst Pharmaceuticals、Merck、Boehringer Ingelheim 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 伝染病治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：HIV、インフルエンザ、結核、マラリア、肝炎、HPV - アプリケーション別分析（2017年vs2021年vs2028年）：病院、診療所、その他 - 世界の伝染病治療薬市場規模・予測 - 世界の伝染病治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Novartis、Gilead、GSK、Janssen Pharmaceutical、Roche、BioCryst Pharmaceuticals、Merck、Boehringer Ingelheim ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：HIV、インフルエンザ、結核、マラリア、肝炎、HPV ・アプリケーション別分析2017年-2028年：病院、診療所、その他 ・伝染病治療薬の北米市場分析 - 伝染病治療薬の北米市場：タイプ別市場規模2017年-2028年 - 伝染病治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・伝染病治療薬のヨーロッパ市場分析 - ：伝染病治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：伝染病治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・伝染病治療薬のアジア太平洋市場分析 - 伝染病治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 伝染病治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・伝染病治療薬の南米市場分析 - 伝染病治療薬の南米市場：タイプ別市場規模2017年-2028年 - 伝染病治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・伝染病治療薬の中東・アフリカ市場分析 - 伝染病治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 伝染病治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Communicable Diseases Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Communicable Diseases Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Communicable Diseases Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While HIV segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Communicable Diseases Drugs include Novartis, Gilead, GSK, Janssen Pharmaceutical, and Roche, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Communicable Diseases Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
HIV
Influenza
TB
Malaria
Hepatitis
HPV
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Communicable Diseases Drugs market are listed below:
Novartis
Gilead
GSK
Janssen Pharmaceutical
Roche
BioCryst Pharmaceuticals
Merck
Boehringer Ingelheim
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Communicable Diseases Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Communicable Diseases Drugs, with price, sales, revenue and global market share of Communicable Diseases Drugs from 2019 to 2022.
Chapter 3, the Communicable Diseases Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Communicable Diseases Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Communicable Diseases Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Communicable Diseases Drugs.
Chapter 13, 14, and 15, to describe Communicable Diseases Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Communicable Diseases Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Communicable Diseases Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 HIV
1.2.3 Influenza
1.2.4 TB
1.2.5 Malaria
1.2.6 Hepatitis
1.2.7 HPV
1.3 Market Analysis by Application
1.3.1 Overview: Global Communicable Diseases Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Communicable Diseases Drugs Market Size & Forecast
1.4.1 Global Communicable Diseases Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Communicable Diseases Drugs Sales in Volume (2017-2028)
1.4.3 Global Communicable Diseases Drugs Price (2017-2028)
1.5 Global Communicable Diseases Drugs Production Capacity Analysis
1.5.1 Global Communicable Diseases Drugs Total Production Capacity (2017-2028)
1.5.2 Global Communicable Diseases Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Communicable Diseases Drugs Market Drivers
1.6.2 Communicable Diseases Drugs Market Restraints
1.6.3 Communicable Diseases Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Communicable Diseases Drugs Product and Services
2.1.4 Novartis Communicable Diseases Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Gilead
2.2.1 Gilead Details
2.2.2 Gilead Major Business
2.2.3 Gilead Communicable Diseases Drugs Product and Services
2.2.4 Gilead Communicable Diseases Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Communicable Diseases Drugs Product and Services
2.3.4 GSK Communicable Diseases Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Janssen Pharmaceutical
2.4.1 Janssen Pharmaceutical Details
2.4.2 Janssen Pharmaceutical Major Business
2.4.3 Janssen Pharmaceutical Communicable Diseases Drugs Product and Services
2.4.4 Janssen Pharmaceutical Communicable Diseases Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Communicable Diseases Drugs Product and Services
2.5.4 Roche Communicable Diseases Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 BioCryst Pharmaceuticals
2.6.1 BioCryst Pharmaceuticals Details
2.6.2 BioCryst Pharmaceuticals Major Business
2.6.3 BioCryst Pharmaceuticals Communicable Diseases Drugs Product and Services
2.6.4 BioCryst Pharmaceuticals Communicable Diseases Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Communicable Diseases Drugs Product and Services
2.7.4 Merck Communicable Diseases Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business
2.8.3 Boehringer Ingelheim Communicable Diseases Drugs Product and Services
2.8.4 Boehringer Ingelheim Communicable Diseases Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Communicable Diseases Drugs Breakdown Data by Manufacturer
3.1 Global Communicable Diseases Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Communicable Diseases Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Communicable Diseases Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Communicable Diseases Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Communicable Diseases Drugs Manufacturer Market Share in 2021
3.5 Global Communicable Diseases Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Communicable Diseases Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Communicable Diseases Drugs Market Size by Region
4.1.1 Global Communicable Diseases Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Communicable Diseases Drugs Revenue by Region (2017-2028)
4.2 North America Communicable Diseases Drugs Revenue (2017-2028)
4.3 Europe Communicable Diseases Drugs Revenue (2017-2028)
4.4 Asia-Pacific Communicable Diseases Drugs Revenue (2017-2028)
4.5 South America Communicable Diseases Drugs Revenue (2017-2028)
4.6 Middle East and Africa Communicable Diseases Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Communicable Diseases Drugs Sales in Volume by Type (2017-2028)
5.2 Global Communicable Diseases Drugs Revenue by Type (2017-2028)
5.3 Global Communicable Diseases Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Communicable Diseases Drugs Sales in Volume by Application (2017-2028)
6.2 Global Communicable Diseases Drugs Revenue by Application (2017-2028)
6.3 Global Communicable Diseases Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Communicable Diseases Drugs Sales by Type (2017-2028)
7.2 North America Communicable Diseases Drugs Sales by Application (2017-2028)
7.3 North America Communicable Diseases Drugs Market Size by Country
7.3.1 North America Communicable Diseases Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Communicable Diseases Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Communicable Diseases Drugs Sales by Type (2017-2028)
8.2 Europe Communicable Diseases Drugs Sales by Application (2017-2028)
8.3 Europe Communicable Diseases Drugs Market Size by Country
8.3.1 Europe Communicable Diseases Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Communicable Diseases Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Communicable Diseases Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Communicable Diseases Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Communicable Diseases Drugs Market Size by Region
9.3.1 Asia-Pacific Communicable Diseases Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Communicable Diseases Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Communicable Diseases Drugs Sales by Type (2017-2028)
10.2 South America Communicable Diseases Drugs Sales by Application (2017-2028)
10.3 South America Communicable Diseases Drugs Market Size by Country
10.3.1 South America Communicable Diseases Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Communicable Diseases Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Communicable Diseases Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Communicable Diseases Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Communicable Diseases Drugs Market Size by Country
11.3.1 Middle East & Africa Communicable Diseases Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Communicable Diseases Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Communicable Diseases Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Communicable Diseases Drugs
12.3 Communicable Diseases Drugs Production Process
12.4 Communicable Diseases Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Communicable Diseases Drugs Typical Distributors
13.3 Communicable Diseases Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Communicable Diseases Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Communicable Diseases Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Communicable Diseases Drugs Product and Services
Table 6. Novartis Communicable Diseases Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Gilead Basic Information, Manufacturing Base and Competitors
Table 8. Gilead Major Business
Table 9. Gilead Communicable Diseases Drugs Product and Services
Table 10. Gilead Communicable Diseases Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GSK Basic Information, Manufacturing Base and Competitors
Table 12. GSK Major Business
Table 13. GSK Communicable Diseases Drugs Product and Services
Table 14. GSK Communicable Diseases Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Janssen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Janssen Pharmaceutical Major Business
Table 17. Janssen Pharmaceutical Communicable Diseases Drugs Product and Services
Table 18. Janssen Pharmaceutical Communicable Diseases Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Roche Basic Information, Manufacturing Base and Competitors
Table 20. Roche Major Business
Table 21. Roche Communicable Diseases Drugs Product and Services
Table 22. Roche Communicable Diseases Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. BioCryst Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. BioCryst Pharmaceuticals Major Business
Table 25. BioCryst Pharmaceuticals Communicable Diseases Drugs Product and Services
Table 26. BioCryst Pharmaceuticals Communicable Diseases Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Basic Information, Manufacturing Base and Competitors
Table 28. Merck Major Business
Table 29. Merck Communicable Diseases Drugs Product and Services
Table 30. Merck Communicable Diseases Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 32. Boehringer Ingelheim Major Business
Table 33. Boehringer Ingelheim Communicable Diseases Drugs Product and Services
Table 34. Boehringer Ingelheim Communicable Diseases Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Communicable Diseases Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Communicable Diseases Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Communicable Diseases Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Communicable Diseases Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Communicable Diseases Drugs Production Site of Key Manufacturer
Table 40. Communicable Diseases Drugs New Entrant and Capacity Expansion Plans
Table 41. Communicable Diseases Drugs Mergers & Acquisitions in the Past Five Years
Table 42. Global Communicable Diseases Drugs Sales by Region (2017-2022) & (K Units)
Table 43. Global Communicable Diseases Drugs Sales by Region (2023-2028) & (K Units)
Table 44. Global Communicable Diseases Drugs Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Communicable Diseases Drugs Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Communicable Diseases Drugs Sales by Type (2017-2022) & (K Units)
Table 47. Global Communicable Diseases Drugs Sales by Type (2023-2028) & (K Units)
Table 48. Global Communicable Diseases Drugs Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Communicable Diseases Drugs Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Communicable Diseases Drugs Price by Type (2017-2022) & (USD/Unit)
Table 51. Global Communicable Diseases Drugs Price by Type (2023-2028) & (USD/Unit)
Table 52. Global Communicable Diseases Drugs Sales by Application (2017-2022) & (K Units)
Table 53. Global Communicable Diseases Drugs Sales by Application (2023-2028) & (K Units)
Table 54. Global Communicable Diseases Drugs Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Communicable Diseases Drugs Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Communicable Diseases Drugs Price by Application (2017-2022) & (USD/Unit)
Table 57. Global Communicable Diseases Drugs Price by Application (2023-2028) & (USD/Unit)
Table 58. North America Communicable Diseases Drugs Sales by Country (2017-2022) & (K Units)
Table 59. North America Communicable Diseases Drugs Sales by Country (2023-2028) & (K Units)
Table 60. North America Communicable Diseases Drugs Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Communicable Diseases Drugs Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Communicable Diseases Drugs Sales by Type (2017-2022) & (K Units)
Table 63. North America Communicable Diseases Drugs Sales by Type (2023-2028) & (K Units)
Table 64. North America Communicable Diseases Drugs Sales by Application (2017-2022) & (K Units)
Table 65. North America Communicable Diseases Drugs Sales by Application (2023-2028) & (K Units)
Table 66. Europe Communicable Diseases Drugs Sales by Country (2017-2022) & (K Units)
Table 67. Europe Communicable Diseases Drugs Sales by Country (2023-2028) & (K Units)
Table 68. Europe Communicable Diseases Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Communicable Diseases Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Communicable Diseases Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Europe Communicable Diseases Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Europe Communicable Diseases Drugs Sales by Application (2017-2022) & (K Units)
Table 73. Europe Communicable Diseases Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Communicable Diseases Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Communicable Diseases Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Communicable Diseases Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Communicable Diseases Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Communicable Diseases Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Communicable Diseases Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Communicable Diseases Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Communicable Diseases Drugs Sales by Application (2023-2028) & (K Units)
Table 82. South America Communicable Diseases Drugs Sales by Country (2017-2022) & (K Units)
Table 83. South America Communicable Diseases Drugs Sales by Country (2023-2028) & (K Units)
Table 84. South America Communicable Diseases Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Communicable Diseases Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Communicable Diseases Drugs Sales by Type (2017-2022) & (K Units)
Table 87. South America Communicable Diseases Drugs Sales by Type (2023-2028) & (K Units)
Table 88. South America Communicable Diseases Drugs Sales by Application (2017-2022) & (K Units)
Table 89. South America Communicable Diseases Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Communicable Diseases Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Communicable Diseases Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Communicable Diseases Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Communicable Diseases Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Communicable Diseases Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Communicable Diseases Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Communicable Diseases Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Communicable Diseases Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Communicable Diseases Drugs Raw Material
Table 99. Key Manufacturers of Communicable Diseases Drugs Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Communicable Diseases Drugs Typical Distributors
Table 103. Communicable Diseases Drugs Typical Customers
List of Figures
Figure 1. Communicable Diseases Drugs Picture
Figure 2. Global Communicable Diseases Drugs Revenue Market Share by Type in 2021
Figure 3. HIV
Figure 4. Influenza
Figure 5. TB
Figure 6. Malaria
Figure 7. Hepatitis
Figure 8. HPV
Figure 9. Global Communicable Diseases Drugs Revenue Market Share by Application in 2021
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Communicable Diseases Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Communicable Diseases Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Communicable Diseases Drugs Sales (2017-2028) & (K Units)
Figure 16. Global Communicable Diseases Drugs Price (2017-2028) & (USD/Unit)
Figure 17. Global Communicable Diseases Drugs Production Capacity (2017-2028) & (K Units)
Figure 18. Global Communicable Diseases Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Communicable Diseases Drugs Market Drivers
Figure 20. Communicable Diseases Drugs Market Restraints
Figure 21. Communicable Diseases Drugs Market Trends
Figure 22. Global Communicable Diseases Drugs Sales Market Share by Manufacturer in 2021
Figure 23. Global Communicable Diseases Drugs Revenue Market Share by Manufacturer in 2021
Figure 24. Communicable Diseases Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Communicable Diseases Drugs Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Communicable Diseases Drugs Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Communicable Diseases Drugs Sales Market Share by Region (2017-2028)
Figure 28. Global Communicable Diseases Drugs Revenue Market Share by Region (2017-2028)
Figure 29. North America Communicable Diseases Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Europe Communicable Diseases Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Communicable Diseases Drugs Revenue (2017-2028) & (USD Million)
Figure 32. South America Communicable Diseases Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Communicable Diseases Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Global Communicable Diseases Drugs Sales Market Share by Type (2017-2028)
Figure 35. Global Communicable Diseases Drugs Revenue Market Share by Type (2017-2028)
Figure 36. Global Communicable Diseases Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 37. Global Communicable Diseases Drugs Sales Market Share by Application (2017-2028)
Figure 38. Global Communicable Diseases Drugs Revenue Market Share by Application (2017-2028)
Figure 39. Global Communicable Diseases Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Communicable Diseases Drugs Sales Market Share by Type (2017-2028)
Figure 41. North America Communicable Diseases Drugs Sales Market Share by Application (2017-2028)
Figure 42. North America Communicable Diseases Drugs Sales Market Share by Country (2017-2028)
Figure 43. North America Communicable Diseases Drugs Revenue Market Share by Country (2017-2028)
Figure 44. United States Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Communicable Diseases Drugs Sales Market Share by Type (2017-2028)
Figure 48. Europe Communicable Diseases Drugs Sales Market Share by Application (2017-2028)
Figure 49. Europe Communicable Diseases Drugs Sales Market Share by Country (2017-2028)
Figure 50. Europe Communicable Diseases Drugs Revenue Market Share by Country (2017-2028)
Figure 51. Germany Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Communicable Diseases Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Communicable Diseases Drugs Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Communicable Diseases Drugs Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Communicable Diseases Drugs Revenue Market Share by Region (2017-2028)
Figure 60. China Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Communicable Diseases Drugs Sales Market Share by Type (2017-2028)
Figure 67. South America Communicable Diseases Drugs Sales Market Share by Application (2017-2028)
Figure 68. South America Communicable Diseases Drugs Sales Market Share by Country (2017-2028)
Figure 69. South America Communicable Diseases Drugs Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Communicable Diseases Drugs Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Communicable Diseases Drugs Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Communicable Diseases Drugs Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Communicable Diseases Drugs Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Communicable Diseases Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Communicable Diseases Drugs in 2021
Figure 81. Manufacturing Process Analysis of Communicable Diseases Drugs
Figure 82. Communicable Diseases Drugs Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source